On October 24, the House Appropriations Committee approved, by voice vote, the FY2002 defense spending bill (as-yet-unnumbered). Several women’s health research programs are funded under the bill: $175 million would be provided for the Department of Defense’s peer-reviewed breast cancer research program, $12 million would be provided for ovarian cancer research, and $4 million would be provided for osteoporosis research.
Funding levels for breast and ovarian cancer remain unchanged from the FY2001 defense spending measure. However, funding for osteoporosis research was reduced by $2 million.
While the committee approved the bill, the committee report will not be filed until next week when the committee is expected to meet again to add funding for homeland defense programs. The measure is expected to be considered by the House late next week.